‘Unacceptable’ Medicine Shortages Lead French Senate To Set Up Task Force
Executive Summary
Medicine shortages are under scrutiny at national and EU level. In France, a newly established Senate task force is hearing evidence from a range of stakeholders including industry and regulators.
You may also be interested in...
Make Them In Europe: The French Solution To Drug Shortages
The French Senate has produced a set of recommendations for tackling the growing problem of medicine shortages in France and the rest of Europe. The industry body Leem says shortages have many causes and that it will work with other stakeholders to find long-term solutions.
EU Survey Shows Wide Variations In How Countries Deal With Drug Shortages
A survey of EU member states has shown wide variations in the way that they deal with shortages and discontinuation of medicines.
EMA Taking Steps To Mitigate ‘Critical’ Product Shortages Due To GMP Problems
The EMA is consulting on changes to the template for declaring non-compliance with good manufacturing practice, as the first step in a revision of the procedures for handling GMP-related shortages of “critical” medicines.